Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors

References

• Rane RA, Karunanidhi S, Jain K, et al. A recent perspective on discovery and development of diverse therapeutic agents inspired from isatin alkaloids. Curr Top Med Chem (Sharjah, United Arab Emirates) 2016;16:1262–89.
   PubMed Web of Science ®Google Scholar
• Hou J, Jin K, Li J, et al. LJNK, an indoline-2,3-dione-based aminopeptidase N inhibitor with promising antitumor potency. Anti-Cancer Drugs 2016;27:496–507.
   PubMed Web of Science ®Google Scholar
• Pape VFS, Toth S, Furedi A, et al. Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Eur J Med Chem 2016;117:335–54.
   PubMed Web of Science ®Google Scholar
• Chen G, Ning Y, Zhao W, et al. Synthesis, neuro-protection and anti-cancer activities of simple isatin mannich and schiff bases. Lett Drug Des Discov 2016;13:395–400.
   Web of Science ®Google Scholar
• Rana S, Blowers EC, Tebbe C, et al. Isatin derived spirocyclic analogues with α-methylene-γ-butyrolactone as anticancer agents: a structure-activity relationship study. J Med Chem 2016;59:5121–7.
   PubMed Web of Science ®Google Scholar
• Premanathan M, Radhakrishnan S, Kulangiappar K, et al. Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl. Indian J Med Res 2012;136:822–6.
   PubMed Web of Science ®Google Scholar
• Pettersson M, ed. Sunitinib (Sutent): an angiogenesis inhibitor. Hoboken (NJ): John Wiley & Sons, Inc; 2010.
   Google Scholar
• Corona A, Meleddu R, Esposito F, et al. Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6. PLoS One 2016;11:e0147225/1-e/18.
   Web of Science ®Google Scholar
• Meleddu R, Distinto S, Corona A, et al. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase. Eur J Med Chem 2015;93:452–60.
   PubMed Web of Science ®Google Scholar
• Tavari M, Malan SF, Joubert J. Design, synthesis, biological evaluation and docking studies of sulphonyl isatin derivatives as monoamine oxidase and caspase-3 inhibitors. MedChemComm 2016. [Epub ahead of print]. doi: 10.1039/C6MD00228E.
   Web of Science ®Google Scholar
• Akdemir A, Guzel-Akdemir O, Karali N, Supuran CT. Isatin analogs as novel inhibitors of Candida spp. β-carbonic anhydrase enzymes. Bioorg Med Chem 2016;24:1648–52.
   PubMed Web of Science ®Google Scholar
• Chundawat TS, Kumari P, Sharma N, Bhagat S. Strategic synthesis and in vitro antimicrobial evaluation of novel difluoromethylated 1-(1, 3-diphenyl-1H-pyrazol-4-yl)-3, 3-difluoro-1, 3-dihydro-indol-2-ones. Med Chem Res 2016. [Epub ahead of print]. doi: 10.1007/s00044-016-1658-z.
   Web of Science ®Google Scholar
• Sahoo S, Mahendrakumar CB, Setty CM. Synthesis, antiinflammatory and antibacterial activities of some substituted isatin and isatin fused with 3-substituted 4-amino-5-mercapto-1, 2, 4-triazoles. Int J Chem Sci 2015;13:613–24.
   Google Scholar
• Roopan SM, Khan FRN, Selvan NT. Synthesis of 1-[(2-chloroquinolin-3-yl)methyl]indoline-2,3-dione derivatives as potential antimicrobials. J Pharm Res 2010;3:950–2.
   Google Scholar
• Wang G, Peng Z, He D, Yan C, Liu W, inventors; Jishou University, Peop. Rep. China. assignee. Coumarin-isatin type compound useful in treatment of diabetes mellitus and its preparation patent CN105237521A; 2016.
   Google Scholar
• Havrylyuk D, Zimenkovsky B, Vasylenko O, et al. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. J Med Chem 2012;55:8630–41.
   PubMed Web of Science ®Google Scholar
• Ibrahim HS, Abou-Seri SM, Tanc M, et al. Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumour-associated carbonic anhydrase isoforms IX and XII. Eur J Med Chem 2015;103:583–93.
   PubMed Web of Science ®Google Scholar
• Ozgun DO, Yamali C, Gul HI, Taslimi P, Gulcin I, Yanik T, et al. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J Enzyme Inhib Med Chem 2016. [Epub ahead of print]. doi: 10.3109/14756366.2016.1149479.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ceruso M, et al. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumour-associated carbonic anhydrase isoform XII. Eur J Med Chem 2016;110:259–66.
   PubMed Web of Science ®Google Scholar
• Guzel-Akdemir O, Akdemir A, Karali N, Supuran CT. Discovery of novel isatin-based sulphonamides with potent and selective inhibition of the tumour-associated carbonic anhydrase isoforms IX and XII. Org Biomol Chem 2015;13:6493–9.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mokhtari RB, Pan J, et al. Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors. Am J Respir Cell Mol Biol 2015;52:183–92.
   PubMed Web of Science ®Google Scholar
• Imtaiyaz Hassan M, Shajee B, Waheed A, et al. Structure, function and applications of carbonic anhydrase isozymes. Bioorg Med Chem 2013;21:1570–82.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Inhibition of carbonic anhydrase IX as a novel anticancer mechanism. World J Clin Oncol 2012;3:98–103.
   PubMedGoogle Scholar
• Swietach P, Hulikova A, Vaughan-Jones RD, Harris AL. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene 2010;29:6509–21.
   PubMed Web of Science ®Google Scholar
• Boron WF. Evaluating the role of carbonic anhydrases in the transport of HCO3-related species. Biochim Biophys Acta 2010;1804:410–21.
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007;26:299–310.
   PubMed Web of Science ®Google Scholar
• Domsic JF, Avvaru BS, Kim CU, et al. Entrapment of carbon dioxide in the active site of carbonic anhydrase II. J Biol Chem 2008;283:30766–71.
   PubMed Web of Science ®Google Scholar
• Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000;80:681–715.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert Opin Ther Pat 2003;13:1545–50.
   Web of Science ®Google Scholar
• Picard F. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Obes Res 2000;8:656–63.
   PubMedGoogle Scholar
• Carta F, Scozzafava A, Supuran CT. Sulphonamides: a patent review (2008-2012). Expert Opin Ther Pat 2012;22:747–58.
   PubMed Web of Science ®Google Scholar
• Suthar SK, Bansal S, Lohan S, et al. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity. Eur J Med Chem 2013;66:372–9.
   PubMed Web of Science ®Google Scholar
• Supuran Claudiu T. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Pala N, Micheletto L, Sechi M, et al. Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry. ACS Med Chem Lett 2014;5:927–30.
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Maccioni E, Distinto S, et al. New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene) amino]benzene-1-sulphonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII. Bioorganic Med Chem Lett 2015;25:3281–4.
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Di Cesare Mannelli L, et al. 6-Substituted sulfocoumarins are selective carbonic anhydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. J Med Chem 2015;58:3975–83.
   PubMed Web of Science ®Google Scholar
• Bozdag M, Ferraroni M, Nuti E, et al. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. Bioorg Med Chem 2014;22:334–40.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Winum J-Y. Carbonic anhydrase IX inhibitors in cancer therapy: an update. Future Med Chem 2015;7:1407–14.
   PubMed Web of Science ®Google Scholar
• De Monte C, Carradori S, Gentili A, et al. Dual cyclooxygenase and carbonic anhydrase inhibition by nonsteroidal anti-inflammatory drugs for the treatment of cancer. Curr Med Chem 2015;22:2812–18.
   PubMed Web of Science ®Google Scholar
• Anighoro A, Bajorath J, Rastelli G. Polypharmacology: challenges and opportunities in drug discovery. J Med Chem 2014;57:7874–87.
   PubMed Web of Science ®Google Scholar
• Rosini M. Polypharmacology: the rise of multitarget drugs over combination therapies. Future Med Chem 2014;6:485–7.
   PubMed Web of Science ®Google Scholar
• Akbaba Y, Akincioglu A, Gocer H, et al. Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins. J Enzyme Inhib Med Chem 2014;29:35–42.
   PubMed Web of Science ®Google Scholar
• Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
   PubMed Web of Science ®Google Scholar
• Senturk M, Gulcin I, Beydemir S, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011;77:494–9.
   PubMed Web of Science ®Google Scholar